← Eichor
Condition: Oral Uremic Toxin Absorbent Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Oral Uremic Toxin Absorbent

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic
NA · 1 location(s) · National Taiwan University Hospital · NCT07333313lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
NA · 1 location(s) · National Taiwan University Hospital · NCT04788914Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function
NA · 1 location(s) · National Taiwan University Hospital · NCT04792320Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
NA · 1 location(s) · National Taiwan University Hospital · NCT04819217
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.